Vector will be at SITC!
Join us at booth #1215 to explore reagents, chemistry, and services for immuno-oncology research.
At the Society for Immunotherapy of Cancer (SITC) Annual Meeting, November 6-7 at the Phoenix Convention Center, Vector Laboratories is showcasing how integrated biology and chemistry support tumor microenvironment analysis and immunotherapy development, from tissue detection to custom biologic design.

Antibodies & Detection Solutions
Validated reagents for spatial biology and IHC and IF cancer research workflows, enabling high-confidence tissue and biomarker analysis.

Conjugation Chemistries & Services
Broad collection of cross-linkers, payload linkers, labels, and bioconjugation services for optimized, customized detection and delivery.

Custom Antibody Services
Recombinant antibody engineering, sequencing, and expression tailored to your unique molecule and requirements.

Glycosylation & Glycobiology
Lectin-based reagents and tools to visualize protein glycosylation in situ for new insights into disease biology, biomarker discovery, and tumor microenvironments.
Attendees
Erika Leonard
Director of R&D
Sabrina Mateos, M.B.A.
Sr. Field Application Scientist
Reese Harry, PhD
Business Development Manager
Sambhav Dave, M.Sc.
Vice President, Global Marketing
Sean Downing, Ph.D., M.B.A.
Chief Scientific Officer
Featured Resource
Novel Tools for Spatial Profiling of Protein Expression and Glycosylation in Brain Pathology
Learn how Glysite Explorer and cleavable fluorescent probes from Spatomics enable spatial imaging of protein expression and glycosylation in complex tissues like cancerous brain tissue.
This poster was presented at SITC 2025.

